This document outlines a research project on using shared decision making (SDM) to guide discussions about biosimilars and biological agents in Latin America. The project will involve two stages: 1) an international survey to understand stakeholders' perspectives on SDM and its applicability to biosimilars, and 2) development and testing of a decision aid tool to facilitate SDM discussions on biosimilars while accounting for cultural factors. The goal is to explore barriers to SDM implementation and develop a validated decision aid to guide discussions and priority setting around biosimilar treatment options in Latin America.
This executive decree modifies regulations regarding the health registration of biological and biotech products in Panama. It establishes new requirements for registering biotech products, including presenting clinical trial data, quality and manufacturing information, risk management programs, and certificates of analysis for each imported batch. Biotech products already registered must now present clinical trials within 60 days to maintain their registration. The decree aims to ensure the efficacy, safety and quality of biopharmaceuticals marketed in Panama.
La FundaciĂłn Junior Achievement Colombia, mejor conocida como Colombia Emprendedora se complace en
presentar a ustedes el programa Mujeres Emprendedoras, que se ejecutarĂĄ gracias al patrocinio de Accenture
Ltda. y con la colaboraciĂłn de la FundaciĂłn Ana Restrepo del Corral.
This document lists the names of several architectural projects including PREPKITCHEN Little Italy, DIGITARIA, Solace & the Mooonlight Lounge, GoPro, Davanti, UCSD International Center, and Indian Wells Tennis GardenâShade Structure.
This executive decree modifies regulations regarding the health registration of biological and biotech products in Panama. It establishes new requirements for registering biotech products, including presenting clinical trial data, quality and manufacturing information, risk management programs, and certificates of analysis for each imported batch. Biotech products already registered must now present clinical trials within 60 days to maintain their registration. The decree aims to ensure the efficacy, safety and quality of biopharmaceuticals marketed in Panama.
La FundaciĂłn Junior Achievement Colombia, mejor conocida como Colombia Emprendedora se complace en
presentar a ustedes el programa Mujeres Emprendedoras, que se ejecutarĂĄ gracias al patrocinio de Accenture
Ltda. y con la colaboraciĂłn de la FundaciĂłn Ana Restrepo del Corral.
This document lists the names of several architectural projects including PREPKITCHEN Little Italy, DIGITARIA, Solace & the Mooonlight Lounge, GoPro, Davanti, UCSD International Center, and Indian Wells Tennis GardenâShade Structure.
The document outlines the history and current state of childcare in Japan. It traces the origins of kindergartens back to 1871 and daycare centers to 1890. Today, the formal childcare system includes kindergartens overseen by the Ministry of Education for children ages 3-5, and daycare centers overseen by the Ministry of Health and Welfare for children ages 0-5. Attendance in preschool education has increased over time and there is a trend toward more free public options. The underlying philosophy focuses on teaching children etiquette, independence, and confidence. Childcare workers require specific training and certificates.
The document provides guidelines for the evaluation of similar biotherapeutic products (SBPs). It outlines key principles for licensing SBPs, which include:
1) Development of a SBP involves stepwise comparability exercises starting with quality comparisons to a reference biotherapeutic product (RBP), with demonstration of similarity a prerequisite for reduced non-clinical and clinical data requirements.
2) Licensing of a SBP is based on its demonstrated similarity to a suitable RBP in quality, non-clinical, and clinical parameters.
3) Comparability exercises include integrated quality, non-clinical and clinical studies to provide comparative data between the SBP and RBP. Differences require investigation and may necessitate additional data.
Guide for elaboration of clinical study reports for biological product regist...Clapbio
Â
This document provides guidance on the minimum content and format required for clinical study reports submitted for biological product registration or post-registration changes. It outlines 20 sections that should be included, such as background on the study design, objectives, treatments, endpoints, results analyses, and conclusions. Adherence to this standard format will help ensure clinical reports contain all necessary information to support regulatory reviews.
Este documento presenta las normas y las instrucciones de un juego de mesa sobre la ciudad de Santiago. Los jugadores avanzan por casillas tirando un dado y respondiendo preguntas sobre lugares y hechos de la ciudad. El juego contiene 23 casillas con sitios emblemĂĄticos de Santiago y 20 preguntas sobre su historia, cultura y sĂmbolos.
El documento presenta las instrucciones para un juego de mesa sobre el Camino de Santiago. Los jugadores deben avanzar por un tablero contestando preguntas sobre la ruta y la ciudad de Santiago. El juego se puede jugar de forma individual o por equipos. El objetivo es ser el primero en llegar a la Catedral de Santiago respondiendo correctamente a las preguntas.
Guide for conducting comparability exercise for biological product registrationClapbio
Â
This document provides guidance for conducting a comparability exercise between a proposed biological product (BP) and an authorized comparator biological product (CBP) for the purpose of biological product registration. It outlines the quality, stability, manufacturing process, and data requirements that must be evaluated and presented in a comparability study to demonstrate that the BP is similar to the CBP, upon which reduced nonclinical and clinical data can be relied. Key aspects that must be compared include quality attributes, samples from manufacturing process stages, stability under stress conditions, and data from multiple batches. Significant unjustified differences found would indicate the products are not similar.
The document summarizes the history and development of kindergarten and daycare centers in Japan. It notes that the first kindergarten was established in 1876, and kindergarten became part of the basic school education system in 1947 under the Ministry of Education. The first daycare center opened in 1890, and they were set up in factories starting in 1894, receiving subsidies beginning in 1908 and becoming classified as child welfare facilities in 1947 under the Ministry of Health and Welfare. Attendance rates for preschool education increased over time, reaching 100% for 4-5 year olds by 1981. Public and private kindergartens and daycares receive different levels of financial support. A basic plan from 2008 aimed to increase
This document outlines regulations for controlling human pharmaceutical products in a national system. It establishes the Ministry of Health and the Institute of Public Health as the competent authorities responsible for regulating pharmaceutical activities including registration, manufacturing, distribution, and advertising. It also assigns responsibilities to Regional Health Departments for authorizing product admission and enforcing compliance. Finally, it provides definitions for 29 key terms related to pharmaceutical quality, safety, and regulation.
Zipcar is a global car sharing service that provides vehicles by the hour or day to both personal and business members. It has over 650,000 members and 9,000 vehicles worldwide. Zipcar allows businesses to save time, money, and hassle compared to owning vehicles or using taxis/rental cars. Employees can reserve vehicles online or via app for meetings, errands, client meetings, and other occasions. Zipcar is also environmentally friendly by taking personally owned vehicles off the road. Business memberships provide discounted hourly rates and other benefits.
This document outlines the development of an experimental enterprise called FoodLoop that tackles the urban food waste problem. The enterprise aims to get every housing estate in Britain composting food waste on site and using the compost to grow fruits and vegetables. It discusses the food waste problem, stakeholders involved, the service and system designed including food waste collection, composting, and growing food. It provides examples of other social enterprises and encourages participants to create their own enterprise idea that connects issues and fits their skills. The document promotes an approach of zooming in and out between specific problems and the bigger picture to develop solutions.
The document discusses a presentation about tourism in Guam. It outlines Guam's mission to build trust between the military and local residents through mutual respect and quality of life concerns. It provides background on Guam's history of developing tourism since 1952. Key facts are presented on Guam's hotel inventory, visitor demographics, and interest groups. A SWOT analysis identifies strengths like beaches and diving, but also weaknesses like infrastructure and attitudes. Opportunities include new Asian markets, but threats include rising costs and local activism. Main issues discussed are over-reliance on Japan, lack of identity, and low visitor retention.
Dr. Thomas Shryock - Historical Perspective and Review of Prior Antibiotic Sy...John Blue
Â
Historical Perspective and Review of Prior Antibiotic Symposia - Dr. Thomas Shryock, Chief Scientific Officer, Antimicrobial Consultants, LLC, from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
CHI's Immunogenicity and Bioassay Summit 2015James Prudhomme
Â
This document summarizes an upcoming conference on immunogenicity assessment and clinical relevance for biopharmaceutical products. The conference will take place November 17-18, 2015 in Baltimore, MD and will include keynote speakers from the FDA and industry. It will feature sessions on regulatory expectations, preclinical studies and risk assessment, different assay formats and technologies, and challenges with immunogenicity assessment. Short courses on related topics will also be offered. The document provides an agenda with session topics, speaker names and affiliations, and descriptions of presentation topics.
This investor presentation summarizes Pressure BioSciences' business and technology. PBI develops and sells instruments and consumables for sample preparation using its patented Pressure Cycling Technology platform. Key points include that PBI has over 275 PCT systems installed, has accomplished revenue growth and debt reduction in recent years, and signed a marketing agreement with SCIEX to co-promote its PCT-SWATH technology for mass spectrometry applications. The presentation outlines PBI's technology applications, market opportunities, customer base, and near-term growth drivers including the SCIEX partnership and new product releases.
OMICS Publishing Group, Journal of Clinical Pharmacology & Biopharmaceutics (CPB) emphasizes the phases of drug development from absorption, disposition, metabolism, excretion interactions and rational design of drug products to deliver the drug at a specific rate to the body in order to optimize the therapeutic effect and minimize any adverse effects. The CPB acts as an interface between academics, those in research and developments, explicates the research on various developmental applications for contemporary drug development and utilization.
Microbiome & Probiotics Forum USA agenda 2017Gavin Hambrook
Â
Here's our new look agenda for the Microbiome and Probiotics Forum in San Diego this November. What do you think?
50+ speakers
30+ sponsors
400+ attendees
PCORI held a special webinar on Friday, August 3, 2012, from 1:00 p.m.â 2:00 p.m. ET, to brief stakeholders on PCORIâs draft Methodology Report and encourage public comment.
The draft report, released July 23, 2012, offers standards to guide health care stakeholders towards the best and most appropriate methods for conducting patient-centered outcomes research.
GTCbio organizes biomedical and biopharmaceutical conferences to facilitate information exchange between industry leaders, academics, and government organizations. Upcoming conferences in January 2010 will focus on cancer drugs in development, cytokines and inflammation, and challenges in global clinical trials. The document provides details on conference topics, speakers, and registration information. Sponsorship opportunities are also described to maximize return on investment through networking.
FoodSENSE - A decision support framework for nutrition and food security inte...ILRI
Â
Presented by Jim Hammond, Mark Caulfield, Esther Omosa, Esther Achandi, Paula Dominguez-Salas, Ronnie Ahumuza, Andrea Spray, Emily Ouma, ILRI, at a stakeholder workshop, Kampala, Uganda, 17 November 2022
This document provides an overview of best practices for ensuring readiness for food safety audits and assessments. It begins with introductions and background on the speaker, Bill McBride. The agenda then outlines topics to be covered, including an overview of food safety audits, understanding common food safety terminology, selecting the appropriate food safety standard, and what it means to be "audit ready". It also provides definitions and objectives of food safety audits. Key points made include criticisms of some auditing practices, the roles and limitations of audits, and information on standards organizations like ISO, GFSI initiatives, and the purpose of establishing the GFSI.
Make Plans to Attend the Number 1 Immunogenicity and Bioassay Event Bringing Together Industry,
Academia and Regulatory Authorities. Featuring 8 FDA Presenters!
The document outlines the history and current state of childcare in Japan. It traces the origins of kindergartens back to 1871 and daycare centers to 1890. Today, the formal childcare system includes kindergartens overseen by the Ministry of Education for children ages 3-5, and daycare centers overseen by the Ministry of Health and Welfare for children ages 0-5. Attendance in preschool education has increased over time and there is a trend toward more free public options. The underlying philosophy focuses on teaching children etiquette, independence, and confidence. Childcare workers require specific training and certificates.
The document provides guidelines for the evaluation of similar biotherapeutic products (SBPs). It outlines key principles for licensing SBPs, which include:
1) Development of a SBP involves stepwise comparability exercises starting with quality comparisons to a reference biotherapeutic product (RBP), with demonstration of similarity a prerequisite for reduced non-clinical and clinical data requirements.
2) Licensing of a SBP is based on its demonstrated similarity to a suitable RBP in quality, non-clinical, and clinical parameters.
3) Comparability exercises include integrated quality, non-clinical and clinical studies to provide comparative data between the SBP and RBP. Differences require investigation and may necessitate additional data.
Guide for elaboration of clinical study reports for biological product regist...Clapbio
Â
This document provides guidance on the minimum content and format required for clinical study reports submitted for biological product registration or post-registration changes. It outlines 20 sections that should be included, such as background on the study design, objectives, treatments, endpoints, results analyses, and conclusions. Adherence to this standard format will help ensure clinical reports contain all necessary information to support regulatory reviews.
Este documento presenta las normas y las instrucciones de un juego de mesa sobre la ciudad de Santiago. Los jugadores avanzan por casillas tirando un dado y respondiendo preguntas sobre lugares y hechos de la ciudad. El juego contiene 23 casillas con sitios emblemĂĄticos de Santiago y 20 preguntas sobre su historia, cultura y sĂmbolos.
El documento presenta las instrucciones para un juego de mesa sobre el Camino de Santiago. Los jugadores deben avanzar por un tablero contestando preguntas sobre la ruta y la ciudad de Santiago. El juego se puede jugar de forma individual o por equipos. El objetivo es ser el primero en llegar a la Catedral de Santiago respondiendo correctamente a las preguntas.
Guide for conducting comparability exercise for biological product registrationClapbio
Â
This document provides guidance for conducting a comparability exercise between a proposed biological product (BP) and an authorized comparator biological product (CBP) for the purpose of biological product registration. It outlines the quality, stability, manufacturing process, and data requirements that must be evaluated and presented in a comparability study to demonstrate that the BP is similar to the CBP, upon which reduced nonclinical and clinical data can be relied. Key aspects that must be compared include quality attributes, samples from manufacturing process stages, stability under stress conditions, and data from multiple batches. Significant unjustified differences found would indicate the products are not similar.
The document summarizes the history and development of kindergarten and daycare centers in Japan. It notes that the first kindergarten was established in 1876, and kindergarten became part of the basic school education system in 1947 under the Ministry of Education. The first daycare center opened in 1890, and they were set up in factories starting in 1894, receiving subsidies beginning in 1908 and becoming classified as child welfare facilities in 1947 under the Ministry of Health and Welfare. Attendance rates for preschool education increased over time, reaching 100% for 4-5 year olds by 1981. Public and private kindergartens and daycares receive different levels of financial support. A basic plan from 2008 aimed to increase
This document outlines regulations for controlling human pharmaceutical products in a national system. It establishes the Ministry of Health and the Institute of Public Health as the competent authorities responsible for regulating pharmaceutical activities including registration, manufacturing, distribution, and advertising. It also assigns responsibilities to Regional Health Departments for authorizing product admission and enforcing compliance. Finally, it provides definitions for 29 key terms related to pharmaceutical quality, safety, and regulation.
Zipcar is a global car sharing service that provides vehicles by the hour or day to both personal and business members. It has over 650,000 members and 9,000 vehicles worldwide. Zipcar allows businesses to save time, money, and hassle compared to owning vehicles or using taxis/rental cars. Employees can reserve vehicles online or via app for meetings, errands, client meetings, and other occasions. Zipcar is also environmentally friendly by taking personally owned vehicles off the road. Business memberships provide discounted hourly rates and other benefits.
This document outlines the development of an experimental enterprise called FoodLoop that tackles the urban food waste problem. The enterprise aims to get every housing estate in Britain composting food waste on site and using the compost to grow fruits and vegetables. It discusses the food waste problem, stakeholders involved, the service and system designed including food waste collection, composting, and growing food. It provides examples of other social enterprises and encourages participants to create their own enterprise idea that connects issues and fits their skills. The document promotes an approach of zooming in and out between specific problems and the bigger picture to develop solutions.
The document discusses a presentation about tourism in Guam. It outlines Guam's mission to build trust between the military and local residents through mutual respect and quality of life concerns. It provides background on Guam's history of developing tourism since 1952. Key facts are presented on Guam's hotel inventory, visitor demographics, and interest groups. A SWOT analysis identifies strengths like beaches and diving, but also weaknesses like infrastructure and attitudes. Opportunities include new Asian markets, but threats include rising costs and local activism. Main issues discussed are over-reliance on Japan, lack of identity, and low visitor retention.
Dr. Thomas Shryock - Historical Perspective and Review of Prior Antibiotic Sy...John Blue
Â
Historical Perspective and Review of Prior Antibiotic Symposia - Dr. Thomas Shryock, Chief Scientific Officer, Antimicrobial Consultants, LLC, from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
CHI's Immunogenicity and Bioassay Summit 2015James Prudhomme
Â
This document summarizes an upcoming conference on immunogenicity assessment and clinical relevance for biopharmaceutical products. The conference will take place November 17-18, 2015 in Baltimore, MD and will include keynote speakers from the FDA and industry. It will feature sessions on regulatory expectations, preclinical studies and risk assessment, different assay formats and technologies, and challenges with immunogenicity assessment. Short courses on related topics will also be offered. The document provides an agenda with session topics, speaker names and affiliations, and descriptions of presentation topics.
This investor presentation summarizes Pressure BioSciences' business and technology. PBI develops and sells instruments and consumables for sample preparation using its patented Pressure Cycling Technology platform. Key points include that PBI has over 275 PCT systems installed, has accomplished revenue growth and debt reduction in recent years, and signed a marketing agreement with SCIEX to co-promote its PCT-SWATH technology for mass spectrometry applications. The presentation outlines PBI's technology applications, market opportunities, customer base, and near-term growth drivers including the SCIEX partnership and new product releases.
OMICS Publishing Group, Journal of Clinical Pharmacology & Biopharmaceutics (CPB) emphasizes the phases of drug development from absorption, disposition, metabolism, excretion interactions and rational design of drug products to deliver the drug at a specific rate to the body in order to optimize the therapeutic effect and minimize any adverse effects. The CPB acts as an interface between academics, those in research and developments, explicates the research on various developmental applications for contemporary drug development and utilization.
Microbiome & Probiotics Forum USA agenda 2017Gavin Hambrook
Â
Here's our new look agenda for the Microbiome and Probiotics Forum in San Diego this November. What do you think?
50+ speakers
30+ sponsors
400+ attendees
PCORI held a special webinar on Friday, August 3, 2012, from 1:00 p.m.â 2:00 p.m. ET, to brief stakeholders on PCORIâs draft Methodology Report and encourage public comment.
The draft report, released July 23, 2012, offers standards to guide health care stakeholders towards the best and most appropriate methods for conducting patient-centered outcomes research.
GTCbio organizes biomedical and biopharmaceutical conferences to facilitate information exchange between industry leaders, academics, and government organizations. Upcoming conferences in January 2010 will focus on cancer drugs in development, cytokines and inflammation, and challenges in global clinical trials. The document provides details on conference topics, speakers, and registration information. Sponsorship opportunities are also described to maximize return on investment through networking.
FoodSENSE - A decision support framework for nutrition and food security inte...ILRI
Â
Presented by Jim Hammond, Mark Caulfield, Esther Omosa, Esther Achandi, Paula Dominguez-Salas, Ronnie Ahumuza, Andrea Spray, Emily Ouma, ILRI, at a stakeholder workshop, Kampala, Uganda, 17 November 2022
This document provides an overview of best practices for ensuring readiness for food safety audits and assessments. It begins with introductions and background on the speaker, Bill McBride. The agenda then outlines topics to be covered, including an overview of food safety audits, understanding common food safety terminology, selecting the appropriate food safety standard, and what it means to be "audit ready". It also provides definitions and objectives of food safety audits. Key points made include criticisms of some auditing practices, the roles and limitations of audits, and information on standards organizations like ISO, GFSI initiatives, and the purpose of establishing the GFSI.
Make Plans to Attend the Number 1 Immunogenicity and Bioassay Event Bringing Together Industry,
Academia and Regulatory Authorities. Featuring 8 FDA Presenters!
This document discusses the challenges of enrolling pediatric patients with rare diseases in clinical trials in Latin America. It provides an example case study of a pediatric rare disease trial that was extended into Latin America. Some of the key enrollment challenges included long regulatory timelines, issues confirming proper patient diagnoses, cultural and communication barriers, and logistical hurdles. To address these challenges, an on-the-ground team was established to directly communicate with physicians, problem solve issues, and act as a liaison between sites, patients, and the sponsor. These efforts helped increase enrollment by 50% and achieve 100% patient retention.
Did you know 40-65% of all clinical trials involving FDA-regulated products are being conducted overseas? Time, reduced costs, and easier subject recruitment are the factors that make life science companies to conduct clinical trials overseas.
This document lists talks given by Ravi S. Harapanhalli, Ph.D. from 2002-2015 on various topics related to pharmaceutical development and regulation. It provides the date, topic, and venue for each talk. The talks covered issues like regulatory considerations for drug development, combination products, biologics, and quality systems. The venues included national and international conferences focused on pharmaceutical research and development.
Roles and Responsibilities in Clinical Trials of Investigator, Study Coordinator, Sponsor, Monitor, a Contract research organization.
The clinical trial, definition, description, Different types of clinical trials, phases of clinical trial.
The clinical trial study team.
Requirements of the clinical trial study team.
Clinical research team role.
GCP- Good clinical practices.
This presentation by Pressure BioSciences discusses their Pressure Cycling Technology platform for biological sample preparation. Some key points:
- PCT uses ultra-high pressure to break up cell walls and extract biomolecules, achieving better results than mechanical methods.
- The market for biological sample preparation is multi-billion dollars. PCT addresses the need for improved sample prep methods.
- Over 275 PCT systems have been installed at over 150 customer sites. There are over 100 publications highlighting PCT's advantages.
- Recent accomplishments include a co-marketing agreement with SCIEX, a leader in analytical technologies, and sales of their new Barocycler 2320EXTREME system.
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...MargaretFarrell
Â
Through this workshop, participants will
not only become familiar with how to use the tools they need to identity and address health outcomes, but
understand the benefits of virtual communities of practice as a means to engage researchers and practitioners around implementing cancer control programs.
will introduce participants to the Cancer Control P.L.A.N.E.T portal and the Research to Reality Community of Practice. (#NCIR2R)
Presentation given at the NATIONAL HEALTH OUTREACH CONFERENCE (#NHOC) Promoting Connections to Create Healthy Individuals, Families and Communities May 8, 2015
The document outlines a strategy and vision for modernizing toxicity testing in the 21st century. It proposes moving away from traditional animal testing approaches and instead focusing on assessing perturbations of toxicity pathways in human cells through high-throughput in vitro screening. This would allow testing a much broader range of chemicals at lower costs and with fewer animals. Computational modeling of dose-response relationships would be used to extrapolate in vitro results for risk assessment purposes. The approach has implications for toxicity testing practices and regulations. Overall, the vision is to create a new paradigm centered on human pathways rather than apical animal outcomes.
IIVS International Practical Trainings on Alternative Test MethodsMarcelo Vieira
Â
This document announces an international practical training workshop on alternative test methods to be held in Brazil. The 3-day workshop in November 2011 will provide lectures on accepted in vitro test methods from national and international speakers, as well as hands-on demonstrations of test methods by IIVS personnel. The workshop aims to educate scientists on the technical protocols, reliability, and regulatory use of alternative test methods. It is organized by multiple organizations and supported by various government, industry, and academic stakeholders to promote the acceptance and standardization of alternative methods in Brazil and globally.
This presentation discusses strategies for protecting the food system from farm to fork. It explains that food can become contaminated at many points and discusses guidelines like HACCP plans and active managerial control that aim to prevent contamination. Public health measures for ensuring food safety include assessing threats, developing evidence-based policies, communicating about risks and outbreaks, and making sure food safety standards are followed. Collaboration between private industry and public health is key to maintaining a secure food system.
Similar to 16 12 11_-_sdm_project[1] [modo de compatibilidade] (20)
This document provides guidelines on evaluating similar biological medicinal products. It outlines the regulatory framework and scope of such products. The key principles are:
1) Comparability studies are required to demonstrate similarity in quality, safety and efficacy between a new product and an authorized reference product.
2) The level of characterization required depends on the product's complexity, with highly purified products more readily characterized than others.
3) Whether a product can use the "similar biological" approach depends on available analytical procedures and manufacturing control, as well as clinical experience. Relevant guidelines are provided for specific types of biological products.
This draft guidance provides recommendations for demonstrating that a proposed therapeutic protein product is biosimilar to an FDA-licensed reference product. It discusses using a stepwise approach and totality-of-the-evidence to assess biosimilarity based on analytical, animal, and clinical studies comparing structure, function, toxicity, pharmacokinetics, immunogenicity, and safety and effectiveness. The guidance also addresses complexities of protein products and manufacturing considerations.
Denizar vianna clap_bio_meeting_rio_dec16th2011 [modo de compatibilidade]Clapbio
Â
This document outlines the objectives of the Centro Latino Americano de Pesquisa em BiolĂłgicos (CLAPBio). CLAPBio aims to strengthen regulatory and economic decision making regarding biosimilars in Latin America through three main objectives: 1) Developing tools and training national teams, 2) Creating an economic model for biosimilars, and 3) Establishing collaborations across organizations in Latin American countries. Key activities include creating guidelines, conducting studies, providing technical support, and launching an online learning platform to disseminate information on biosimilars. The overall goal is to support informed and evidence-based decisions regarding biosimilar approval and adoption in the region.
16 12 11_sdm_concepts[2] [modo de compatibilidade]Clapbio
Â
O documento discute a tomada de decisĂŁo compartilhada em saĂșde, definindo o conceito, questĂ”es prioritĂĄrias de pesquisa e como implementĂĄ-la na prĂĄtica clĂnica, com foco no papel das ferramentas de apoio Ă decisĂŁo.
This document outlines regulations for controlling human pharmaceutical products in a national system. It establishes the Ministry of Health and the Institute of Public Health as the competent authorities responsible for regulating pharmaceutical activities including registration, manufacturing, distribution, and advertising. It also assigns responsibilities to Regional Health Departments for authorizing product admission and enforcing compliance. Finally, it provides definitions for 29 key terms related to pharmaceutical quality, safety, and regulation.
7075 11 iname establece requisitos para registro de especialidades medicina...Clapbio
Â
La UniĂłn Europea ha acordado un paquete de sanciones contra Rusia por su invasiĂłn de Ucrania. Las sanciones incluyen restricciones a los bancos rusos, la prohibiciĂłn de exportaciones de alta tecnologĂa a Rusia y la congelaciĂłn de activos de oligarcas rusos. Los lĂderes de la UE esperan que estas medidas disuadan a Rusia de continuar su agresiĂłn militar contra Ucrania.
Technical note about biological products 19 10 11Clapbio
Â
The document discusses Brazil's interest in promoting domestic production of biotechnological products as patents expire globally. It outlines Brazil's regulatory framework for approving biologics, including two pathways for approving non-innovative copies based on comparability studies. Recent regulatory changes aim to provide guidelines supporting domestic development of biologic copies while ensuring safety and efficacy.
This document establishes new regulations for the registration of biological medicinal products in Argentina. It defines biological products and outlines specific requirements and procedures for their registration, including information that must be included in registration certificates. Evaluation and approval of registration applications will ensure biological products have favorable benefit-risk ratios, sufficient therapeutic efficacy, adequate quality and composition supported by application materials.
1) O documento fornece diretrizes para o desenvolvimento e avaliação de produtos bioteråpicos similares (PBSs).
2) PBSs são produtos biológicos projetados para serem similares a um produto bioteråpico original licenciado, mas requerem sua própria avaliação de qualidade, segurança e eficåcia.
3) As diretrizes abordam questĂ”es de qualidade, avaliação nĂŁo-clĂnica e clĂnica necessĂĄrias para o licenciamento de PBSs de forma a garantir nĂveis aceitĂĄveis de qualidade
âBuilding and Scaling AI Applications with the Nx AI Manager,â a Presentation...Edge AI and Vision Alliance
Â
For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2024/06/building-and-scaling-ai-applications-with-the-nx-ai-manager-a-presentation-from-network-optix/
Robin van Emden, Senior Director of Data Science at Network Optix, presents the âBuilding and Scaling AI Applications with the Nx AI Manager,â tutorial at the May 2024 Embedded Vision Summit.
In this presentation, van Emden covers the basics of scaling edge AI solutions using the Nx tool kit. He emphasizes the process of developing AI models and deploying them globally. He also showcases the conversion of AI models and the creation of effective edge AI pipelines, with a focus on pre-processing, model conversion, selecting the appropriate inference engine for the target hardware and post-processing.
van Emden shows how Nx can simplify the developerâs life and facilitate a rapid transition from concept to production-ready applications.He provides valuable insights into developing scalable and efficient edge AI solutions, with a strong focus on practical implementation.
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!SOFTTECHHUB
Â
As the digital landscape continually evolves, operating systems play a critical role in shaping user experiences and productivity. The launch of Nitrux Linux 3.5.0 marks a significant milestone, offering a robust alternative to traditional systems such as Windows 11. This article delves into the essence of Nitrux Linux 3.5.0, exploring its unique features, advantages, and how it stands as a compelling choice for both casual users and tech enthusiasts.
Building RAG with self-deployed Milvus vector database and Snowpark Container...Zilliz
Â
This talk will give hands-on advice on building RAG applications with an open-source Milvus database deployed as a docker container. We will also introduce the integration of Milvus with Snowpark Container Services.
âIâm still / Iâm still / Chaining from the BlockâClaudio Di Ciccio
Â
âAn Outlook of the Ongoing and Future Relationship between Blockchain Technologies and Process-aware Information Systems.â Invited talk at the joint workshop on Blockchain for Information Systems (BC4IS) and Blockchain for Trusted Data Sharing (B4TDS), co-located with with the 36th International Conference on Advanced Information Systems Engineering (CAiSE), 3 June 2024, Limassol, Cyprus.
Introducing Milvus Lite: Easy-to-Install, Easy-to-Use vector database for you...Zilliz
Â
Join us to introduce Milvus Lite, a vector database that can run on notebooks and laptops, share the same API with Milvus, and integrate with every popular GenAI framework. This webinar is perfect for developers seeking easy-to-use, well-integrated vector databases for their GenAI apps.
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionAggregage
Â
Join Maher Hanafi, VP of Engineering at Betterworks, in this new session where he'll share a practical framework to transform Gen AI prototypes into impactful products! He'll delve into the complexities of data collection and management, model selection and optimization, and ensuring security, scalability, and responsible use.
Why You Should Replace Windows 11 with Nitrux Linux 3.5.0 for enhanced perfor...SOFTTECHHUB
Â
The choice of an operating system plays a pivotal role in shaping our computing experience. For decades, Microsoft's Windows has dominated the market, offering a familiar and widely adopted platform for personal and professional use. However, as technological advancements continue to push the boundaries of innovation, alternative operating systems have emerged, challenging the status quo and offering users a fresh perspective on computing.
One such alternative that has garnered significant attention and acclaim is Nitrux Linux 3.5.0, a sleek, powerful, and user-friendly Linux distribution that promises to redefine the way we interact with our devices. With its focus on performance, security, and customization, Nitrux Linux presents a compelling case for those seeking to break free from the constraints of proprietary software and embrace the freedom and flexibility of open-source computing.
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...James Anderson
Â
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
Enchancing adoption of Open Source Libraries. A case study on Albumentations.AIVladimir Iglovikov, Ph.D.
Â
Presented by Vladimir Iglovikov:
- https://www.linkedin.com/in/iglovikov/
- https://x.com/viglovikov
- https://www.instagram.com/ternaus/
This presentation delves into the journey of Albumentations.ai, a highly successful open-source library for data augmentation.
Created out of a necessity for superior performance in Kaggle competitions, Albumentations has grown to become a widely used tool among data scientists and machine learning practitioners.
This case study covers various aspects, including:
People: The contributors and community that have supported Albumentations.
Metrics: The success indicators such as downloads, daily active users, GitHub stars, and financial contributions.
Challenges: The hurdles in monetizing open-source projects and measuring user engagement.
Development Practices: Best practices for creating, maintaining, and scaling open-source libraries, including code hygiene, CI/CD, and fast iteration.
Community Building: Strategies for making adoption easy, iterating quickly, and fostering a vibrant, engaged community.
Marketing: Both online and offline marketing tactics, focusing on real, impactful interactions and collaborations.
Mental Health: Maintaining balance and not feeling pressured by user demands.
Key insights include the importance of automation, making the adoption process seamless, and leveraging offline interactions for marketing. The presentation also emphasizes the need for continuous small improvements and building a friendly, inclusive community that contributes to the project's growth.
Vladimir Iglovikov brings his extensive experience as a Kaggle Grandmaster, ex-Staff ML Engineer at Lyft, sharing valuable lessons and practical advice for anyone looking to enhance the adoption of their open-source projects.
Explore more about Albumentations and join the community at:
GitHub: https://github.com/albumentations-team/albumentations
Website: https://albumentations.ai/
LinkedIn: https://www.linkedin.com/company/100504475
Twitter: https://x.com/albumentations
A tale of scale & speed: How the US Navy is enabling software delivery from l...sonjaschweigert1
Â
Rapid and secure feature delivery is a goal across every application team and every branch of the DoD. The Navyâs DevSecOps platform, Party Barge, has achieved:
- Reduction in onboarding time from 5 weeks to 1 day
- Improved developer experience and productivity through actionable findings and reduction of false positives
- Maintenance of superior security standards and inherent policy enforcement with Authorization to Operate (ATO)
Development teams can ship efficiently and ensure applications are cyber ready for Navy Authorizing Officials (AOs). In this webinar, Sigma Defense and Anchore will give attendees a look behind the scenes and demo secure pipeline automation and security artifacts that speed up application ATO and time to production.
We will cover:
- How to remove silos in DevSecOps
- How to build efficient development pipeline roles and component templates
- How to deliver security artifacts that matter for ATOâs (SBOMs, vulnerability reports, and policy evidence)
- How to streamline operations with automated policy checks on container images
Climate Impact of Software Testing at Nordic Testing DaysKari Kakkonen
Â
My slides at Nordic Testing Days 6.6.2024
Climate impact / sustainability of software testing discussed on the talk. ICT and testing must carry their part of global responsibility to help with the climat warming. We can minimize the carbon footprint but we can also have a carbon handprint, a positive impact on the climate. Quality characteristics can be added with sustainability, and then measured continuously. Test environments can be used less, and in smaller scale and on demand. Test techniques can be used in optimizing or minimizing number of tests. Test automation can be used to speed up testing.
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdfMalak Abu Hammad
Â
Discover how MongoDB Atlas and vector search technology can revolutionize your application's search capabilities. This comprehensive presentation covers:
* What is Vector Search?
* Importance and benefits of vector search
* Practical use cases across various industries
* Step-by-step implementation guide
* Live demos with code snippets
* Enhancing LLM capabilities with vector search
* Best practices and optimization strategies
Perfect for developers, AI enthusiasts, and tech leaders. Learn how to leverage MongoDB Atlas to deliver highly relevant, context-aware search results, transforming your data retrieval process. Stay ahead in tech innovation and maximize the potential of your applications.
#MongoDB #VectorSearch #AI #SemanticSearch #TechInnovation #DataScience #LLM #MachineLearning #SearchTechnology
Securing your Kubernetes cluster_ a step-by-step guide to success !KatiaHIMEUR1
Â
Today, after several years of existence, an extremely active community and an ultra-dynamic ecosystem, Kubernetes has established itself as the de facto standard in container orchestration. Thanks to a wide range of managed services, it has never been so easy to set up a ready-to-use Kubernetes cluster.
However, this ease of use means that the subject of security in Kubernetes is often left for later, or even neglected. This exposes companies to significant risks.
In this talk, I'll show you step-by-step how to secure your Kubernetes cluster for greater peace of mind and reliability.
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...Neo4j
Â
Leonard Jayamohan, Partner & Generative AI Lead, Deloitte
This keynote will reveal how Deloitte leverages Neo4jâs graph power for groundbreaking digital twin solutions, achieving a staggering 100x performance boost. Discover the essential role knowledge graphs play in successful generative AI implementations. Plus, get an exclusive look at an innovative Neo4j + Generative AI solution Deloitte is developing in-house.
27. Schedule
Write the project in detail 1m
Forms preparation 1m
1m
Submission to Institutionals Review Board
Interviewers screening and training 2m
Contact with persons in charge of the 1m
sites to be included in the study
Patients enrollment 6m
Follow-up 12
m
Data input and information validation 2m
Data analysis 2m
Results discussion 2m
Preparation of the report/manuscript for 1m
publication
Total, months 27